Advertisement
Screener

Tribute Pharmaceuticals Canada Inc. Interest Expense, Other

Tribute Pharmaceuticals Canada Inc. Interest Expense, Other

Tribute Pharmaceuticals Canada Inc. reported Interest Expense, Other of CAD 35.94 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-09.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpenseOther · last filed 2016-01-29

  • Tribute Pharmaceuticals Canada Inc. interest expense, other for the quarter ending 2015-09-30 was 35.94K CAD, a 21.07% increase year-over-year.
  • Tribute Pharmaceuticals Canada Inc. interest expense, other for the quarter ending 2015-06-30 was 34.05K CAD, a 22.25% increase year-over-year.
  • Tribute Pharmaceuticals Canada Inc. interest expense, other for the quarter ending 2015-03-31 was 26.45K CAD, a 6.79% increase year-over-year.
  • Tribute Pharmaceuticals Canada Inc. interest expense, other for the quarter ending 2014-09-30 was 29.68K CAD, a 5.06% decline year-over-year.
Period endInterest Expense, Other 3 monthInterest Expense, Other 6 monthInterest Expense, Other 9 month
2015-09-3035.94K CAD
10-Q · filed 2015-11-09
69.99K CAD
derived: sum of 2 quarters · filed 2016-01-29
96.33K CAD
10-Q · filed 2015-11-09
2015-06-3034.05K CAD
10-Q · filed 2016-01-29
60.50K CAD
10-Q · filed 2016-01-29
2015-03-3126.45K CAD
10-Q · filed 2015-05-12
2014-09-3029.68K CAD
10-Q · filed 2015-11-09
57.54K CAD
derived: sum of 2 quarters · filed 2016-01-29
82.30K CAD
10-Q · filed 2015-11-09
2014-06-3027.85K CAD
10-Q · filed 2016-01-29
52.62K CAD
10-Q · filed 2016-01-29
2014-03-3124.76K CAD
10-Q · filed 2015-05-12
2013-09-3031.26K CAD
10-Q · filed 2014-11-10
70.06K CAD
derived: sum of 2 quarters · filed 2014-11-10
137.09K CAD
10-Q · filed 2014-11-10
2013-06-3038.80K CAD
10-Q · filed 2014-08-11
92.76K CAD
10-Q · filed 2014-08-11
2013-03-3153.97K CAD
10-Q · filed 2014-05-15
2012-09-3058.64K CAD
10-Q · filed 2013-11-14
89.42K CAD
derived: sum of 2 quarters · filed 2013-11-14
89.94K CAD
10-Q · filed 2013-11-14
2012-06-3030.78K CAD
10-Q · filed 2013-08-13
30.78K CAD
10-Q · filed 2013-08-13